In Vitro Breast Cancer Models as Useful Tools in Therapeutics?
23 -Simplicity The relevance of cellular models is controversial since their over-simplicity implies difficulties in extrapolating results from the cell line to the tumour in humans and thus raises the question of their representativeness. Indeed, cell lines are homogeneous, theoretically consisting only of a single cell type (pure and clonal) due to the way they are established: -The dislocation of tumours is followed by isolation of cells, in order to obtain the most stable culture during subcultures. -
The culture conditions eliminate some types of cells present in the original tumour, unable to grow on a synthetic surface, or whose rate of development is much lower than the one of the surviving cells. -Cells in culture do not undergo the influence of nervous and hormonal regulatory systems active in vivo. These particularities reduce the similarity with the primary tumour.
Limited representativeness The hundred of available cell lines do not cover all of the tumour features found in patients. Furthermore, the proportions of some characteristics are sometimes reversed, such as the ER and PgR status which is very different in cell lines, compared to that found in the patient population (Lacroix & Leclercq 2004) . These dissimilarities can be explained by the fact that most lines are derived from pleural effusion and metastases containing cells which are already different from the original tumour and thus, more or less representative of this tumour. Indeed, the ER/PgR status sometimes differs between the metastasis and the original tumour from the same patient. Based on these observations, several teams have worked on the development of cell lines derived from a primary tumour (Amadori et al. 1993; Gazdar et al. 1998; Shen et al. 2009 ), which are much more representative of the in vivo cancerous tissues that lines derived from metastases, but which suffer from the same problems related to their relative homogeneity and instability in a long term use. Moreover, the establishment of cell lines from primary tumours remains a difficult achievement, failures mainly being the result of contamination by the stroma surrounding the tumour. -Confusion with some cell lines Besides these previous drawbacks, many criticisms have been made against BCCL because some of them have been proven not being from breast cancer origin. Indeed, some lines were contaminated by other cell types during their first years of use, then spread to other laboratories, and used on a large scale without further verifications of their true origin. Several cell lines were denounced as false, whereas it was not the case (Fogh et al. 1977; Nelson-Rees & Flandermeyer 1977) . These contaminations have been subjects of controversial for a long time. However, studies have shown with certitude that two cell lines were not from their supposed origin. The MCF-7-ADRr cell line was developed in 1986 by Batist. It is derived from the lineage of human mammary adenocarcinoma MCF-7 and was rendered resistant to adriamycin treatment after exposition to increased concentrations of this drug. The obtained resistant cell line was also resistant to other agents such as actinomycin D, vinblastine and vincristine. However in 1998, the lineage between MCF-7 and MCF-7-ADRr became controversial, as shown by DNA fingerprinting studies and genetic comparison, so that the true origin of the cell line was undetermined and the cell line was renamed NCI/ADR-RES. Liscovitch and Ravid, in 2007, have collected data showing that NCI/ADR-RES were carcinoma ovarian cells (Liscovitch & Ravid 2007) , and experiments of Affymetrix SNP array analysis at the Sanger Institute (Cancer Genome Project) and of karyotyping, helped to put in evidence an indisputable resemblance of NCI/ADR-RES with the OVCAR-8 human ovarian carcinoma cell line. The most likely scenario is that the stock of MCF-7 cells from the National Cancer Institute used in 1986 for the development of the lineage, was contaminated with OVCAR-8 cells before the first generation of MCF-7-ADR-r. OVCAR-8 cells are naturally resistant to adriamycin, and the in vitro selection probably eliminated the MCF-7 cells and allowed the survival of OVCAR-8 cells (Liscovitch & Ravid 2007) . It can be noted that MCF-7-ADRr are no longer distributed by the international cell bank ATCC. The second misidentification concerns the MDA-MB-435 cell line established by Cailleau and colleagues in 1978 . This cell line has been controversial in 2000, further to the results of DNA microarray analysis which suggested that these cells might be of melanocyte origin (Ross & Perou 2001) . Some other results, obtained by microsatellite comparison analysis, karyotyping and comparative genomic hybridisation experiments (Rae et al. 2007) , confirmed that MDA-MB-435 cells are in fact M14 melanoma cells. However, these two cell lines, MCF-7-ADRr and MDA-MB-235, are still used as breast cancer cell lines for some studies and are used for publications in international journals, while it has been proven that they are not from breast cancer origin (Lacroix 2008) . The verification of the origin of a cell line is essential, and a way of ensuring that the cell lines are really from a well-defined origin is to make a short tandem repeat (STR) profiling. This method is used to confirm the identity of a cell line by comparison to a known profile and a periodic re-authentication of cell lines is advisable. Moreover, banks of cell lines such as ATCC guarantee the exact origin of their cells. Several authors suggested to prove the authenticity of the cell lines used for each publications (Burdall et al. 2003; Lacroix 2008) .
Non cancerous immortalised cells as controls
It should be noticed that the study of mammary tumours also involves the use of non cancerous cells which were immortalised. These cell lines were derived from healthy breast tissue, but only few models, obtained by different methods, are available.

The immortalisation could be the consequence of a particular composition of the growth medium. This is the case for the non-tumourigenic epithelial cell lines MCF-10A (adherent cells) and MCF-10F (floating cells) which were established from the same sample in the nineties (Soule et al. 1990 ). These cell lines were produced by a long-term culture in a special medium containing a low concentration of Ca 2+ and no serum addition, which resulted in the apparition of immortalised cells with normal features of mammalian epithelial cells.  Two other cell lines were derived from a mammoplastic surgery. These cells named MCF-12A and MCF-12F became spontaneously immortal after unexpected exposition to high temperatures (45°C during 72 hours, Pauley et al. 1991 (Stampfer 1989 ). The use of these "non cancerous" cell lines is important to give a comparison point to results obtained with cancerous cell lines. However, there are drawbacks and controversy to their use, the major one concerning the way they were obtained. Indeed, if they are still nontumourigenic, they suffer of genetic modifications which lead them to become immortal. They are looking like normal cells, but they are not.
Breast cell lines and metabolism of therapeutic drugs -
Drug metabolism The metabolic equipment of a cell can explain its sensitivity/resistance to drugs. Indeed, any xenobiotic molecule (therapeutic drugs included) undergoes the same metabolic fate in the cells. Briefly, enzymes of Phase I (essentially cytochromes P450 (CYP) dependent enzymes) ensure a bioactivation of the molecules while enzymes of Phase II conjugate the metabolites issued from Phase I to endogenous molecules (glucuronic acid, glutathione, sulfates…) in order to make them more water-soluble and to facilitate their elimination. Finally, transporters of Phase III are responsible for exporting these last products out of the cells. Each human organ is equipped with these enzymes, but their expression pattern differs quantitatively and qualitatively. The liver is the most efficient organ in metabolising processes, even if we know that some enzymes are more specifically expressed in non hepatic tissues. When considering the usefulness of breast cell lines as in vitro tools to predict sensitivity or resistance to a molecule, it is easy to perform, in first line, simple cytotoxicity tests. However, in order to explain the reasons of these cells behavior, or to predict the metabolism of a new compound, the knowledge of the metabolic equipment of the cells is necessary. As it is impossible, and not very interesting, to decline the results of the literature concerning breast cell lines and assays with the numerous chemical molecules which have been, precisely or not precisely, tested, we chose two examples of therapeutic drugs, used in breast cancer, that need to be bioactivated by CYP before exerting their deleterious effects in the cells: oxazaphosphorines and ellipticine. -Metabolism of oxazaphosphorines The oxazaphosphorines generally used in pharmacology (i.e. cyclophosphamide (CPA), ifosfamide (IFO), and trofosfamide) represent an important group of chemotherapeutic agents. However, their use is limited by severe toxic side effects. New oxazaphosphorines derivatives have been developed in order to improve selectivity and to reduce toxicity but they won't be studied here, due to their bioactivation process which is different from that of previous molecules (Zhang et al. 2005) . Both CPA and IFO, the most widely used as alkylating agents, are prodrugs whose metabolism involves different cytochromes P450 (CYPs) catalysing 4-hydroxylations leading to acrolein and nitrogen mustards capable of reacting with DNA molecules leading to cell apoptosis and/or necrosis. Another pathway consists in an N-dealkylation whose last product is the toxic chloroacetaldehyde ( Figure 1 ) (Rooseboom et al. 2004; Zhang et al. 2005) . All these metabolites are highly reactive metabolites responsible for urotoxicity, neurotoxicity and nephrotoxicity. As all the mechanisms underlying these toxicities are not elucidated, Mesna (Sodium 2-mercaptoethanesulfonate) is often used to limit these side effects (Giraud et al. 2010) . As already mentioned, several CYPs are involved in these drug metabolism: CYP2B6 (Wang & Tompkins 2008; Mo et al. 2009; Bray et al. 2010) , CYP3A4 (Kivisto et al. 1995) , but also CYP2A6 (Di et al. 2009 ), CYP2C9, CYP2C19, CYP3A5 (Bray et al. 2010 ) and probably others. No analog study was performed in breast tissue, and a fortiori in breast cancer cell lines. However, the literature reports the presence of CYP3A4 (the CYP enzyme the most involved in drug metabolism) in MCF-7, T47D and MDA-MB-231 (Nagaoka et al. 2006; Chen et al. 2009; Mitra et al. 2011) , of CYP2B6 in MCF-7 and T47D (Lo et al. 2010 ) whereas this information is not available for MDA-MB-231. While CYP2D6 and splicing variants similar to those found in breast cancer tissues were shown expressed in MCF-7 (Huang et al. 1997) , no information about this CYP, to our knowledge, was related for T47D and MDA-MB-231. Metabolism of ellipticine Another example is given by ellipticine. This alkaloid compound found in several plants (Ochrosia, Aspidoserma subincanum, Bleekeria vitiensis) is a topoisomerase poison often used in ovarian and breast cancer treatment. It is also a prodrug whose efficiency depends on CYP activation. 13-hydroxy-and 12-hydroxy-ellipticine, responsible for the formation of DNA adducts, are generated by CYP1A1/2, CYP3A4 and CYP2C9. Members of the CYP1 family are usually expressed in extrahepatic tissues and it is not strange to find CYP1A1 in MCF-7 (Androutsopoulos et al. 2009; Stiborova et al. 2011) , in MDA-MB-231 and T47D . We already mentioned the presence of CYP3A4 in the three cell lines, but no precise information is available for CYP2C9. This slight overview shows that the three main breast cancer cell lines are able to give interesting information about drugs that have to be bioactivated before exerting their deleterious effects in cancer cells. However, we must keep in mind that polymorphic variants of the genes coding these enzymes, or splicing variants, may influence the pharmacology of any drugs. Very few information about that are available in patients, but no study was performed in breast cancer cells. BCCL have been created to study tumour development and related mechanisms and to test molecules potentially active. They are inevitable models for many studies. However, their extensive use in all areas of research on breast cancer remains sometimes controversial due to the over simplicity of the model, the instability of the strain, the existence of "false cell lines" and the failures of representativeness of the tumour. Thus, it clearly appears that these models are not sufficient to answer all the questions on breast cancer, and it is essential to turn to complementary models. Consequently, new models were introduced in the late 70s. They were used to a lesser extent than cell lines for a long time, but they tend to be more used now.
Improving representativeness of the model: Direct culture of tumour fragment
There are several methods to circumvent the problem of representativeness of BCCL, e.g. the direct culture of tumour fragments. The first attempts in this direction were made in the late 60s from tumours of 1mm 3 volume (Matoska & Stricker 1967) . However, these cultures were proven difficult due to the high thickness of the samples, preventing the diffusion of nutrients and oxygen to the center of the sample, and thus, avoiding a long-term cultivation in vitro. This method has been modified over time, and with the use of microtome, problems associated with diffusion of nutrients have been resolved. The samples are now constituted of extremely thin slices of about 150 to 200 µM thick (Nissen et al. 1983) . This type of model was used to study the different inter-tumoural cell interactions and also to test the sensitivity to drugs (Milani et al. 2010) . The slice tumour model associated with the development of microscopic analysis methods, such as the triple-fluorescence viability assay developed by Van Der Kuip, allowed the study of the cytotoxic effect of Taxol on this breast cancer model (Van Der Kuip et al. 2006) . Another example of drug study is the evaluation of the action of cytokines and cytotoxic drugs on animal (MMTV-Neu mice) breast cancer slices, especially the monitoring of apoptosis increase and DNA damage after treatment with interferon-gamma or doxorubicin (Parajuli & Doppler 2009 ). The last noticeable example is the use of a tropism-modified oncolytic adenovirus, and a wild-type adenovirus on these slices to treat breast cancer. The results showed that the modified oncolytic adenovirus can infect and replicate in breast cancer tissue slices, suggesting the great potential of this model for evaluating the potential of oncolytic adenovirus constructs (Pennington et al. 2010 ). This list is not exhaustive and the literature shows that a lot of results were obtained by the slice culturing method, more particularly on the study of drugs effects like tamoxifen or paclitaxel (Conde et al. 2008; Sonnenberg et al. 2008; Rajendran et al. 2011) . Although used since the late 70's, the slice technique evolved over time and was adapted to technological innovations. We may especially underline the use of silicon sensor chips wearing electrodes and sensors as a carrier of culture slice. The samples are deposited on the chip and data concerning the tumour-slice are analysed continuously during its cultivation and during its contact with drugs; measurements are made in real-time by the readout of ionic-sensitive field effect transistors and an oxygen electrode. This model was used to study the effects of Taxol on 200 slices of breast cancer, which revealed a dose-dependent decrease of the metabolic activity showed by the measurement of a decrease in the acidification of the medium (Mestres et al. 2006) . This technique has advantages and drawbacks. The direct culture of tumour fragment has the major advantage of preserving tissue architecture and all the cell populations constituting the human tumour. This method is thus a valuable technique which permits to take into account the whole tumour environment in vivo, allowing the investigation of the role of 3-dimensional structures and stromal interactions in tumour. It also allows to study the response of a particular tumour type to environmental stimulations, drugs, and cytokines under well-defined and reproducible conditions. However, the culture of tumour samples presents limitations that do not allow its widespread use. Obtaining tumour samples is submitted to ethical constraints relative to the use of patient samples for research. In addition, it must be performed under ideal conditions. Thus, the samples have to be prepared very quickly after their excision, which means that the research laboratory should have particular facilities to have a direct access to fresh tissues. Moreover, the samples excised by the surgeon are becoming smaller and smaller, due to early diagnoses, and the major part of the samples is kept for diagnosis. Then, if some sample is still available for research, priority is given to research on biomarkers of the tumour in order to give personalised therapies, and, only after, it is disposable for fundamental research. Additionally to the availability restrictions, the same sample cannot be used for many tests because of the limitations of growth of this tissue in vitro. Repetition of assays and comparative measurements are thus more difficult with this model. The use of samples from animal models with mammary tumour partially resolves the problem of availability of samples, but it also raises questions on the representativeness of the samples with human breast tumours. High improvements for providing human tissues of good quality will be brought by the emergence of biobanks.
Circumventing the lack of diversity: Co-culturing of cell lines
The co-culturing represents another way to circumvent the lack of cell diversity found in cell lines and to allow understanding of the tumoural proliferation mechanisms and intercellular interactions within a tumour. It is an indispensable tool to elucidate the regulation of the tumour by epithelial and stromal components surrounding it. This model can be used by different ways: co-culturing of two cell types with a direct contact or co-culturing with a separating porous membrane between both cell types. The first method implicates to be able to differentiate the two cell types by microscopy. For that the use of fluorescent markers is a valuable tool (see Figure 4 for an example of co-culture of MDA-MB-231 with hASCs (adipose stem cells) respectively stained by the lipophilic tracers DiI (dialkylindocarbocyanines) and DiO (dialkyloxacarbocyanines), Pinilla et al. 2009 ). The second method allows a relative isolation of the two cell types, the porosity of the membrane separating them allowing the exchange of substances. The two techniques give complementary information on the behavior of cells studied, especially the crucial role of the inter-cellular communication (Cappelletti et al. 1991) . In example, we could cite the co-culture of MDA-MB-231 and MCF-7, which has highlighted the importance of the heterogeneity of tumours for their growth and the role of oestrogen receptors. In this study, the co-culture of MCF-7 and MDA-MB-231 (respectively ER+ and ER-) in a membrane separation system, was characterised by an increase of the MCF-7 cells growth rate in comparison with monocultures. This suggests that complex interactions between heterogenous cells population in tumour could explain the variability in tumour progression between different patients and the failure in response to endocrine treatment for some patients with ER+ tumours. Another example concerns the direct co-culturing of MCF-10A, a non-cancerous breast cell line, with the cancerous one MCF-7. An exposure to hormonal treatment with 17 -estradiol was able to inhibit the proliferation of MCF-7 cells in this co-culture, whereas this phenomenon was not observed in a monoculture of MCF-7. This highlighted the complex interactions between ER+ MCF-7 and ER-MCF-10A cells which may reflect physiologically relevant mechanisms of the paracrine regulation of cell proliferation (Spink et al. 2006) . The co-culture of MCF-7 with fibroblasts derived from normal biopsies or from cancer biopsies also allowed to highlight the crucial role of fibroblasts in breast tumours. The results of two studies, one in direct co-culturing (Samoszuk et al. 2005 ) the second in membrane separated system (Dong- Le Bourhis et al. 1997) , showed that MCF-7 growth rate was inhibited by fibroblasts issued from non cancerous tissues, but not by fibroblasts issued from tumourous tissues or serum-activated fibroblasts which enhanced MCF-7 growth rate. This suggests that fibroblasts could release some tumour growth inhibiting or activating factors. The role of tumour-associated macrophages in the proliferation of tumour cells was also studied by co-culturing macrophages with MCF-7 cells in a membrane separated system. This co-culture lead to a significant increase of MCF-7 invasiveness in vitro (Hagemann et al. 2004 ).
These repeatable techniques have permitted to highlight the regulation of mammary tumours by the surrounding stroma and the complex interactions between the cell subtypes of the tumour.
A model with a tumour-like structure and cell diversity: 3-D culture
Another particular model allows cells to grow in 3-dimensions, generally with a matrix support (Yuhas et al. 1978) . This type of culture permits an in vitro depiction of tumour tissue more accurate than classical 2-dimensional cultures in monolayers, as this last model does not correctly imitate the architecture and cellular gradients of oxygen and nutrients that are found in poorly vascularised regions of the tumour. Only few cell lines are spontaneously able to establish spheroid architectures under certain culture conditions, but most of the systems require the use of synthetic or non-synthetic matrix. Systems are most often made of agar matrices or collagen support (Kim et al. 2004b ). The Figure 5 show the growth of a MCF-7 spheroid growth in a hydrogel agarose matrix system (Fritsch et al. 2010) . Co-culturing of multiple cell types on these 3-dimensional systems is often used to study the relationship between cells, while simulating the tumour architecture with the most fidelity. These systems generally implicate the cultivation of tumour cells with other cell types like stromal, endothelial, fibroblasts and immune-competent cells. Moreover, this type of model, structurally like-looking the tumour, can be used quite indefinitely because it relies on the use of immortalised cells lines. This allows circumventing the problem of the lack of samples which is the major drawback of the tumour fragment culturing. More advanced systems have been derived from this principle; one can cite the microfluidicbased 3-dimensional culturing (Bauer et al. 2010 ) that allows to grow multicellular tumour spheroid on a microchannel support, in order to analyze complex and heterotypic cellular interactions between breast cancer cells and fibroblast from the surrounding stroma. It has many advantages compared to the standard 3D culture: the culture volume and the number of needed cells are smaller than in standard support, the molecules are only distributed by diffusion mechanisms and the model is adapted to high throughput screenings.
Xenografts: An intermediary model between cell lines and in vivo models
We previously saw that some in vitro models tend to provide essential information on the inter-cellular interactions, by taking more or less into account the 3-dimensional structure of the tumour, but none of them benefit from the nervous and hormonal regulations found in the living organism. There are particular models which can do perfectly the junction between in vitro and in vivo models, the xenografts. They are obtained by injecting cancer cells, usually derived from established cell lines, into a living organism. They are called xenografts because the injected cells are of human origin but are introduced into an animal organism, usually an immunodeficient rodent. The injection can be orthotopic (in breast gland) or heterotopic (localised in another part of the body, usually subcutaneously). The xenograft model has the advantage of using cells from human tumour cell lines for which a significant amount of data was collected in vitro, and to study their behavior in vivo. There are several models available for research on breast cancer, principally using immunodeficient mice. The model nude is by far the most commonly used (Kim et al. 2004a) . It is characterised by an absence of a functional thymus and active T cells (Kindred 1971) . The second common model is the SCID mouse (severe combined immunodeficiency). These mice have a deficit in VDJ recombinases that allow the binding of specific and non-specific parts of immunoglobulin and T cell receptor (Bosma & Carroll 1991) . See Figure 6 illustrating the two common models of mice used for breast cancer xenografts: nude and SCID.
A B The first experiments of cell transplantations were made in the 80s, and opened onto success in the establishment of malignant tumours in nude mice (Ozzello & Sordat 1980; Kim et al. 2004a (Skelding et al. 2009 ). See Figure 7 illustrating the effect of the virus on xenografted mice, visualised by bioluminescent analysis. In the investigation of new treatments, the vitamin D3 receptors constitute good targets as they are present in over 80% of mammary tumours and they are negative growth regulator of both oestrogen-dependent and independent breast cancer cells in vitro. In a study published in 1998 it was shown that EB1089, a vitamin D3 analog, was able to highly reduce the growth of tumour in nude mice xenografted with MCF-7 cells (tumours were 4-fold smaller than those in untreated mice). This reduction was resulting from an enhancement of apoptosis and reducing proliferation of tumour epithelial cells, suggesting the great potential of vitamin D3 analogs such as EB1089 against human breast cancer (VanWeelden et al. 1998) . This model can also be used to explore new potential targets for anticancer therapies. A good example is the targeting of receptor ER . In an experiment, standard T47D ER + ERand modified T47D ER + ER + (T47D stably transfected with a plasmid allowing the expression of the receptor ER ), were xenografted in SCID mice. 17 -estradiol was then injected into mice. The treatment triggered an acceleration of tumour growth in mice xenografted with the native T47D strain, and conversely a regression of tumours T47D ER +. These results emphasize the antagonistic role of ER receptors that appear to play an antitumourigenic role, and offered prospects for the development of ER-selective inhibitors. (Hartman et al. 2006) . The targets cited above are non exhaustive. Many other therapeutic targets are tested with xenografts models, as it is the case of the VEGF pathway implicated in tumour angiogenesis (Le et al. 2008 ), or of cell cycle regulating proteins such as CDK kinases (Fry et al. 2004) . The use of established cell lines for producing xenografts raises several questions about their relevance. The murine model presents considerable differences with the human body, concerning the biochemical and physiological regulation. Moreover, the stroma that will grow surround the tumour will be of murine origin and it will result in a chimeric tumour which biology may significantly differ from human one (Kim et al. 2004a) . Furthermore, in humans, the immune system plays an important role in the fight against tumour, whereas in xenografts models the immune system is totally absent. The xenograft model has some limitations but is the most accomplished of all models because it takes into account the complexity of the organism. Besides the xenografts, there are also murine models which can develop tumours spontaneously or under the influence of inducing compounds (Russo & Russo 1996) . Although the achievement of these models is easy, their use is largely debated because of their relevance to the clinical situation. Indeed, murine breast cancers are most often caused by viral infections and are not hormone dependent, whereas a considerable proportion of human cancers are oestrogen dependent. To date there is no evidence suggesting a viral induction of breast cancer in humans. The biology of spontaneous rodent tumours differs from the human ones. The size, the oncogenic targets or the degree of maturation and differentiation of cells differ between the two species, making them hardly comparable.
Conclusion
In this chapter, we described the main models used in breast cancer research in order to obtain results of high scientific quality. In summary, we can say that BCCL models allow repeatable experiments with simple material and methods. They are inevitable models for basic studies and mechanistic explorations, but their use is still controversial owing to their approximate representativeness of breast tumours in human and to the existence of misidentified cell lines. Cultures of cancerous tissues preserve the tumour architecture and the cell diversity of a tumour but this model suffers of limited reproducibility and cannot be easily maintained for a long time. Co-culture systems offer an alternative with reproducible long term culture systems, and offer the possibility to study the relations between different types of cells in tumour, but this model suffers from the same controversies as BCCL as it mainly relies on their use. 3-dimensional systems allow the mimicking of the tumour architecture and microenvironment, but very few cell lines are able to form spheroids under specific conditions. Considering the advantages and drawbacks of these models, the xenografts appear to be good alternative models as they enable to take into account the tumour structure, its microenvironment, the role of the metabolism and they preserve the cell diversity of the tumour. But as other models, they also have drawbacks principally due to the metabolic and physiological differences existing between human and rodents, and to the fact that the role of the immune system against tumour is not taken into account with the immunodeficient rodent models used for xenografts. Application of the 3Rs principle leaded to the development of all these models, but we showed that none of them is sufficient by itself and able to perfectly mimic breast cancer in human. However it clearly appears that all these models are essential to accumulate data and information to fight breast cancer.
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